Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More

TiGenix

There’s a growing stream of stem cell good news of late. Stem cell biotech, TiGenix, reported encouraging Phase 3 allogeneic results on stem cells. A big milestone. I can’t wait to see the actual data. Its product, Cx601, has so far been safe and effective for perianal fistulas in Crohn’s disease. See more from Alexey on this. CIRM has funded the largest …

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More Read More »